QUOTED. Jeff Shuren.
Jeff Shuren, director of the US FDA’s Device Center was recently quizzed by the House health subcommittee on why the new user-fee deal had reached Congress late, among other issues. See what Shuren said about it here.
Jeff Shuren, director of the US FDA’s Device Center was recently quizzed by the House health subcommittee on why the new user-fee deal had reached Congress late, among other issues. See what Shuren said about it here.